Telescope Strengthens Investor Communications Strategy
March 12, 2026 — Telescoped has rescoped previously announced digital marketing agreements
Telescope Innovations Installs Second Self-Driving Lab at Pfizer
February 23, 2026 — Installation of second Physical AI platform positions Telescope Innovations to successfully address the rapidly expanding SDL market
Telescope Innovations Delivers Continued Strong Sales Revenue Growth in First Fiscal Quarter 2026
January 30, 2026 — The Company generated revenues of $2.7 million during this period.
Telescope Innovations Expands Lithium Development Infrastructure and Achieves Key Material Validation Milestones
January 27, 2026 — The Company is pleased to provide an update on the progress of its lithium processing portfolio.
Telescope Innovations Plans Expansion of DirectInject-LC™ Technology Ecosystem to Fuel the Physical AI Revolution
January 20, 2026 — Telescope is currently developing two new advanced analytical versions: DirectInject-IC™, and DirectInject-ICP™.
Telescope Innovations Outlines Global Market Opportunity for Self-Driving Labs and the Rising Adoption of Physical AI
January 5, 2026 — Telescope provides a strategic update regarding the accelerating commercial adoption of Self-Driving Labs (SDLs) and the global expansion of Physical AI.
Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
December 23, 2025 — The Company generated revenues of $5.8 million during FY25, with an Adjusted EBITDA loss of $402K
Telescope Innovations Installs Korea’s First Self-Driving Lab for Pharma R&D and Education
December 9, 2025 — Rapid three-week deployment, onsite support from two-time Nobel Laureate, and deep Canada-Korea collaboration underscore accelerating commercial momentum
Telescope announces debt settlement transaction
October 23, 2025 — The Company has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a “Share”) of the Company (the “Debt Settlement”).
Telescope issues Stock Options and Shares for debt
October 15, 2025 — The Company has granted 1,544,000 incentive stock options (the “Options”) to certain directors, employees and consultants.
